FDA Committee Gives New Cancer Surgery Tech a Positive Vote FDA Committee Gives New Cancer Surgery Tech a Positive Vote

Although most of the FDA ' s Medical Imaging Drugs Advisory Committee supported LUMISIGHT (pegulicianine), which aims to detect residual cancer during lumpectomy, some cite safety concerns.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news